113
de yapılması gerekliliği bildirilmiştir. Bu genelgede aynı zamanda ilköğretim
okullarındaki tüm öğrencilerin eksik aşılarının tamamlanması ve aşısız çocuk
kalmaması hedeflenmektedir (18).
Kaynaklar
1.
Hepatitis B virus: a comprehensive strategy for eliminating transmission in the
United States through universal childhood vaccination. Recommendations of
the Immunization Practices Advisory Committee (ACIP). Morbid Mortal Wkly Rep
1991;40(RR-13):1-25.
2.
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical
model to estimate global hepatitis B disease burden and vaccination impact.
International J Epidemiol 2005;34:1329–39.
3.
Dumolard L, Gacic-Dobo M, Shapiro CN et al. Implementation of newborn hepatitis
B vaccination – worldwide, 2006. Morbid Mortal Wkly Rep 2008;57:1249–52.
4.
Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review.
Clin Infect Dis 1995;20:992–1000.
5.
Amirzargar AA, Mohseni N, Shokrgozar MA, et al. HLA-DRB1, DQA1 and DQB1
alleles and haplotypes frequencies in Iranian healthy adult responders and non-
responders to recombinant hepatitis B vaccine. Iranian J Immunol 2008;5:92–9.
6.
Viviani S, Jack A, Hall AJ, et al. Hepatitis B vaccination in infancy in The Gambia:
protection against carriage at 9 years of age. Vaccine 1999;17:2946–2950.
7.
Bialek SR, Bower WA, Novak R, et al. Persistence of protection against hepatitis
B virus infection among adolescents vaccinated with recombinant hepatitis
B vaccine beginning at birth: a 15-year follow-up study. Ped Infect Dis J
2008;27:881–5.
8.
Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in
newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by
administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind
randomised placebo-controlled study. Lancet 1984,1:921–6.
9.
Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H.
Immunogenicity of hepatitis B vaccines. Implications for persons at occupational
risk of hepatitis B virus infection. Am J Prevent Med 1998;15:1–8.
10.
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Hepatitis B immunisation for newborn
infants of hepatitis B surface antigen-positive mothers. Cochrane Database Syst
Rev 2006;(2):CD004790.
11.
Marion SA, Tomm Pastore M, Pi DW, Mathias RG. Long-term follow-up of hepatitis
B vaccine in infants of carrier mothers. Am J Epidemiol 199;140:734–46.
12.
Centers for Disease Control and Prevention. A comprehensive immunization
strategy to eliminate transmission of hepatitis B virus infection in the United States:
recommendations of the Advisory Committee on Immunization Practices (ACIP); Part
1: Immunization of Infants, Children, and Adolescents. MMWR 2005;54(No. RR-16):1-32.
13.
Centers for Disease Control and Prevention. A Comprehensive Immunization
Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United
States Recommendations of the Advisory Committee on Immunization Practices
(ACIP) Part II: Immunization of Adults. MMWR 2006;55(No. RR-16):1-33.
Hepatit B Enfeksiyonunda Korunma: Aşı ve profilaksi
